Literature DB >> 2881211

Ligand binding to the beta-adrenergic receptor involves its rhodopsin-like core.

R A Dixon, I S Sigal, E Rands, R B Register, M R Candelore, A D Blake, C D Strader.   

Abstract

Recently the genes for several hormone receptors that interact with guanine nucleotide binding proteins (G proteins) have been cloned, including the hamster beta 2-adrenergic receptor (beta 2AR), a human beta AR, the turkey erythrocyte beta AR and the porcine muscarinic acetylcholine receptor (MAR). All these receptors share some amino-acid homology with rhodopsin, particularly in 7 hydrophobic stretches of residues that are believed to represent transmembrane helices. To determine whether differences in ligand specificity result from the divergence in the sequences of the hydrophilic regions of these receptors, we have expressed in mammalian cells genes for the wild-type hamster and human beta AR proteins, and a series of deletion mutant genes of the hamster beta 2AR. The pharmacology of the expressed receptors indicates that most of the hydrophilic residues are not directly involved in the binding of agonists or antagonists to the receptor. In addition, we have identified a mutant receptor that has high agonist affinity but does not couple to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881211     DOI: 10.1038/326073a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  54 in total

1.  Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor.

Authors:  P Ghanouni; J J Steenhuis; D L Farrens; B K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Prediction of structure and function of G protein-coupled receptors.

Authors:  Nagarajan Vaidehi; Wely B Floriano; Rene Trabanino; Spencer E Hall; Peter Freddolino; Eun Jung Choi; Georgios Zamanakos; William A Goddard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-26       Impact factor: 11.205

3.  Substitutions in the hydrophobic core of the alpha-factor receptor of Saccharomyces cerevisiae permit response to Saccharomyces kluyveri alpha-factor and to antagonist.

Authors:  L Marsh
Journal:  Mol Cell Biol       Date:  1992-09       Impact factor: 4.272

Review 4.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors.

Authors:  T M Savarese; C M Fraser
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

5.  The N-terminal region of the dopamine D2 receptor, a rhodopsin-like GPCR, regulates correct integration into the plasma membrane and endocytic routes.

Authors:  D I Cho; C Min; K S Jung; S Y Cheong; M Zheng; S J Cheong; M H Oak; J H Cheong; B K Lee; K M Kim
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  CGEMA and VGAP: a Colour Graphics Editor for Multiple Alignment using a variable GAP penalty. Application to the muscarinic acetylcholine receptor.

Authors:  H Moereels; L De Bie; J P Tollenaere
Journal:  J Comput Aided Mol Des       Date:  1990-06       Impact factor: 3.686

Review 7.  The 5-HT1A receptor: an overview of recent advances.

Authors:  S el Mestikawy; A Fargin; J R Raymond; H Gozlan; M Hnatowich
Journal:  Neurochem Res       Date:  1991-01       Impact factor: 3.996

8.  Human beta-adrenergic receptors. Simultaneous purification of beta 1- and beta 2-adrenergic-receptor peptides.

Authors:  S W Bahouth; C C Malbon
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

Review 9.  Structure-function of alpha1-adrenergic receptors.

Authors:  Dianne M Perez
Journal:  Biochem Pharmacol       Date:  2006-09-16       Impact factor: 5.858

10.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.